Posted by on Feb 24, 2019 in Urinary incontinence | 0 comments

In a nutshell

This trial is evaluating an implanted device, ProACT, for the treatment of stress urinary incontinence (SUI) in men. The main outcome to be measured is an improvement of patient quality of life and the device remaining in good condition long term. This trial is being carried out in Georgia and Michigan, the United States. 

The details

Stress incontinence is urine leakage when there is pressure on the bladder. It is often observed when a patient coughs, sneezes or exercises. It happens as a result of weak muscles around the bladder that help hold urine in. It can be treated by pelvic floor exercises, drug therapy, pessaries (to support the walls of the bladder) or nerve stimulation. Surgery can also be an option when these treatments do not work. 

ProACT is an implanted device which squeezes the neck of the bladder to stop urine from leaking. This trial is evaluating the long-term safety and effectiveness of the ProACT device. The main outcome to be measured is an improvement of patient quality of life and the device remaining in good condition long term.

Who are they looking for?

145 patients are needed for this trial. To be included in this trial, patients must be willing and able to have surgery to implant the device and be able to comply with trial instructions and follow-up activities for 5 years. Patients must have 2 positive 24-hour pad tests and should not have a urinary infection or active urinary or genital cancers, other than treated prostate cancer. Patients must be determined as a suitable candidate for surgery by a doctor. 

Patients will not be included in the trial if they have a narrow urethra (the tube where urine comes out from the bladder) or if it was removed. Patients cannot have an artificial urinary sphincter or any components of it still in their body. Patients who have bladder stones, a bleeding disorder or uncontrolled diabetes will no be included in the trial. 

How will it work

All patients will receive the ProACT device. Patients will be followed for 5 years after implantation. Patients will be assessed for quality of life, urinary symptoms and the condition the device is in. 

Clinical trial locations

Locations near 20147, United States (Change):
Please enter zip/postal code and country to help us offer locations near you
Show only recruiting locations
Type:Interventional
Participants:145
Study ID:NCT03767595
Want personalized notifications? Get notified only when trials are matching for you.
(it's free)